Swedbank’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,786
Closed -$106K 726
2022
Q4
$106K Sell
3,786
-321
-8% -$8.21K ﹤0.01% 700
2022
Q3
$96.1K Hold
4,107
﹤0.01% 727
2022
Q2
$139K Sell
4,107
-76,250
-95% -$2.67M ﹤0.01% 724
2022
Q1
$2.81M Hold
80,357
0.01% 595
2021
Q4
$2.47M Sell
80,357
-60,406
-43% -$1.97M ﹤0.01% 624
2021
Q3
$4.62M Sell
140,763
-184,969
-57% -$5.92M 0.01% 560
2021
Q2
$9.86M Buy
+325,732
New +$10.7M 0.02% 475

Other funds holding OGN

Swedbank's OGN Position: Q1 2023 in Review

Swedbank sold out of Organon & Co (OGN) in Q1 2023, closing a stake of 3,786 shares — an estimated $106K sold.

Swedbank first reported a position in OGN in Q2 2021 and held it in 7 quarters. The position peaked at $9.86M in Q2 2021. 767 funds tracked by Wall St. Rank hold OGN as of Q1 2023.

  • Swedbank reported no remaining Organon & Co position as of Q1 2023 after selling out during the quarter.
  • Swedbank sold 3,786 Organon & Co shares in Q1 2023, an estimated $106K.
  • Swedbank first reported a position in Organon & Co in Q2 2021 and held it in 7 quarters.
  • Swedbank's Organon & Co position peaked at $9.86M in Q2 2021.
  • 767 funds tracked by Wall St. Rank held Organon & Co as of Q1 2023.

Based on Swedbank's 13F filing for Q1 2023, filed 6 Dec 2024.